The Streptococcus pyogenes CRISPR-Cas9 system effectively mediates RNA-guided DNA double-strand breaks and is used for genome editing in many different organisms, including plants （Puchta, 2016）. CRISPR-Cas9 is a tw...The Streptococcus pyogenes CRISPR-Cas9 system effectively mediates RNA-guided DNA double-strand breaks and is used for genome editing in many different organisms, including plants （Puchta, 2016）. CRISPR-Cas9 is a two-component system in which the Cas9 protein is expressed from a Pol II promoter （Lowder et al., 2015）. In contrast, the sgRNAs are typically expressed from Pol III promoters, such as U6 and U3.展开更多
Embryonic stem cells （ESCs） are capable of unlimited selfrenewal and differentiation, thus generating remarkable interest in their potential therapeutic use in cell-based tissue engineering and regeneration. Stem ce...Embryonic stem cells （ESCs） are capable of unlimited selfrenewal and differentiation, thus generating remarkable interest in their potential therapeutic use in cell-based tissue engineering and regeneration. Stem cell based therapy has been considered as the most promising therapeutic strategy for a range of debilitating diseases （Reynolds and Lamba, 2014）.展开更多
文摘The Streptococcus pyogenes CRISPR-Cas9 system effectively mediates RNA-guided DNA double-strand breaks and is used for genome editing in many different organisms, including plants （Puchta, 2016）. CRISPR-Cas9 is a two-component system in which the Cas9 protein is expressed from a Pol II promoter （Lowder et al., 2015）. In contrast, the sgRNAs are typically expressed from Pol III promoters, such as U6 and U3.
文摘Embryonic stem cells （ESCs） are capable of unlimited selfrenewal and differentiation, thus generating remarkable interest in their potential therapeutic use in cell-based tissue engineering and regeneration. Stem cell based therapy has been considered as the most promising therapeutic strategy for a range of debilitating diseases （Reynolds and Lamba, 2014）.
